Electromed (NYSE:ELMD) CFO Sells $428,966.35 in Stock

Electromed, Inc. (NYSE:ELMD) CFO Bradley Nagel sold 11,801 shares of the firm’s stock in a transaction dated Thursday, June 4th. The stock was sold at an average price of $36.35, for a total value of $428,966.35. Following the completion of the sale, the chief financial officer directly owned 19,638 shares in the company, valued at $713,841.30. The trade was a 37.54% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link.

Electromed Price Performance

NYSE ELMD opened at $37.18 on Thursday. The stock has a market capitalization of $307.85 million, a PE ratio of 49.57 and a beta of 0.53. Electromed, Inc. has a 1 year low of $17.73 and a 1 year high of $40.00. The business’s 50-day moving average is $30.28 and its 200 day moving average is $28.03.

Institutional Trading of Electromed

Hedge funds have recently made changes to their positions in the stock. Allspring Global Investments Holdings LLC boosted its position in shares of Electromed by 717.0% in the 4th quarter. Allspring Global Investments Holdings LLC now owns 106,005 shares of the company’s stock worth $3,087,000 after purchasing an additional 93,030 shares in the last quarter. Hsbc Holdings PLC bought a new stake in shares of Electromed in the 4th quarter worth approximately $358,000. Hunter Associates Investment Management LLC boosted its position in shares of Electromed by 25.1% in the 1st quarter. Hunter Associates Investment Management LLC now owns 150,800 shares of the company’s stock worth $3,529,000 after purchasing an additional 30,250 shares in the last quarter. North Star Investment Management Corp. bought a new stake in shares of Electromed in the 1st quarter worth approximately $796,000. Finally, Punch & Associates Investment Management Inc. boosted its position in shares of Electromed by 6.6% in the 4th quarter. Punch & Associates Investment Management Inc. now owns 187,020 shares of the company’s stock worth $5,446,000 after purchasing an additional 11,500 shares in the last quarter. 40.82% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

Several analysts have commented on ELMD shares. B. Riley Financial raised their price objective on shares of Electromed from $38.00 to $40.00 and gave the stock a “buy” rating in a report on Wednesday, May 13th. Zacks Research upgraded shares of Electromed from a “hold” rating to a “strong-buy” rating in a report on Wednesday, May 13th. Finally, Roth Mkm restated a “buy” rating and issued a $38.00 price objective on shares of Electromed in a report on Wednesday, February 11th. One equities research analyst has rated the stock with a Strong Buy rating and three have given a Buy rating to the company’s stock. According to data from MarketBeat, the stock has a consensus rating of “Buy” and a consensus price target of $37.50.

Electromed Company Profile

Electromed Inc (NYSE: ELMD) develops and manufactures sleep therapy products designed to support individuals with breathing disorders such as obstructive sleep apnea. The company’s core business activities include the design, production and distribution of continuous positive airway pressure (CPAP) and bilevel positive airway pressure (BiPAP) accessories. Electromed’s focus on supplying both disposable and reusable components allows durable medical equipment providers to offer comprehensive therapy solutions to patients.

The company’s product portfolio encompasses masks, mask cushions, headgear, tubing, filters and humidification components.